APA

Levy R. J., Lumry W. R., McNeil D. L., Li H. H., Campion M., Horn P. T. & Pullman W. E. (20100708). EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Chicago

Levy Robyn J, Lumry William R, McNeil Donald L, Li H Henry, Campion Marilyn, Horn Patrick T and Pullman William E. 20100708. EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Harvard

Levy R. J., Lumry W. R., McNeil D. L., Li H. H., Campion M., Horn P. T. and Pullman W. E. (20100708). EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

MLA

Levy Robyn J, Lumry William R, McNeil Donald L, Li H Henry, Campion Marilyn, Horn Patrick T and Pullman William E. EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 20100708.